SCHEMBL18372136

SCHEMBL18372136

O=P(c1ccccc1)(c1ccccc1)c1ccc(-c2ccc(-c3ccc(-c4c5ccccc5c(-c5ccccc5)c5c6ccccc6c6ccccc6c45)cc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.40
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MMP8 P22894 1/20 0.35
▸ MMP14 P50281 1/20 0.35
▸ CA14 Q9ULX7 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ MAPT P10636 3/20 0.34
▸ HTT P42858 2/20 0.34
▸ ACP3 P15309 4/20 0.34
▸ PTPN5 P54829 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA4 P22748 1/20 0.33
▸ CA5A P35218 1/20 0.33
▸ TOP1 P11387 1/20 0.33
▸ ESR1 P03372 1/20 0.32
▸ ALDH1A1 P00352 2/20 0.32
▸ KDM4E B2RXH2 2/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18372163 1.00 LMNA (0.40) LMNANPSR1MMP8MMP14CA14
SCHEMBL18372115 1.00 LMNA (0.40) LMNANPSR1MMP8MMP14CA14
SCHEMBL20746673 0.92 NPSR1 (0.38) LMNANPSR1MMP8MMP14CA14
SCHEMBL18372118 0.90 NPSR1 (0.36) LMNANPSR1MAPTHTTACP3
SCHEMBL11962353 0.89 LMNA (0.44) LMNANPSR1MMP8MMP14CA14
SCHEMBL20967392 0.89 LMNA (0.44) LMNANPSR1MMP8MMP14CA14
SCHEMBL15479311 0.89 LMNA (0.44) LMNANPSR1MMP8MMP14CA14
SCHEMBL15479322 0.89 LMNA (0.44) LMNANPSR1MMP8MMP14CA14
SCHEMBL22639305 0.88 MEN1 (0.35) LMNANPSR1MEN1KMT2AMAPT
SCHEMBL13454345 0.87 LMNA (0.46) LMNANPSR1MMP8MMP14CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10211404-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-02-19 — — US disclosed
US-20170012209-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-01-12 — — US disclosed
US-20170012209-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012209-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE PIEZO1, TERT, TPR LMNA 2224/4885NPSR1 4592/4885MMP8 4094/4885
US-10211404-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element and electronic device PIEZO1, TERT, TPR LMNA 2224/4885NPSR1 4592/4885MMP8 4094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback